|
|
|
Effexor XrCNN Wyeth (up $0.43 to $46.50, Research) bills its drug Effexor XR as the world's top selling antidepressant. The numbers bear this out, but they're slipping. ... Drug makers face headache as patents expire Dec 18, 2005 Austin American-Statesman (subscription), ...challengers. In 1997, Wyeth patented Effexor XR to improve on its initial version and extend the antidepressant's sales life until 2010. ... Decision Resources Forecasts the Five Drugs that Will Achieve ... Dec 20, 2005 Yahoo! News (press release) For example, sales of Wyeth's blockbuster antidepressant Effexor XR were flat in 2005, a reversal that the company attributed in part to increased competition ... |
|
Home Copyright phasechange.org 2006. All Rights Reserved. |